1/3
Net Contents:   3 x 0.5 mL

Arachidonic Acid is for use in routine platelet aggregation studies for the differential diagnosis of aspirin-like release defects and Storage Pool Disease.

  • Assess the Effect of Aspirin on Platelet Aggregation

  • Detect the Presence of Aspirin-like Release Defects

  • Evaluate the Inhibition of TX A2 Production

  • Confirm Patient Compliance when Aspirin Monotherapy or Dual Antiplatelet Therapy (DAPT) are Prescribed

  • Shelf Life of Two Years

Catalog No.  101297

ARACHIDONIC ACID

Sodium Arachidonate

PRODUCT DETAILS

Arachidonic Acid is a fatty acid present in the granules and membranes of human platelets.

It is liberated from phospholipids and, in the presence of the enzyme cyclo-oxygenase, incorporates oxygen to form the endoperoxide prostaglandin G2 (PGG2).  PGG2 is then quickly transformed to prostaglandin H2 (PGH2) which in turn is converted to thromboxane A2 a potent inducer of platelet aggregation. Ingestion of aspirin or aspirin-containing compounds inhibits cyclo-oxygenase mediated oxygen consumption, thus precluding all subsequent events leading to platelet aggregation.

English_Flag.png
Spanish_Flag.png
French_Flag.png
German_Flag.png
Italy_Flag.png
YOU MAY ALSO BE INTERESTED IN:

ADP

AggRecetin®

15mg

AggRecetin%20Box%20and%20Vials%20020620%

AggRecetin®

100mg

AggRecetin%20Bulk%20Box%20and%20Vials%20

Collagen

Collagen%20Box%20and%20Vials%20020620%20

Epinephrine